| Class | CCY | SZE(M) | WAL | MO | SP | FI | DR | KR | C/E | LTV | TYPE | BNCH | GDNC | SPRD | CPN | YLD | PRICE |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A-1A | USD | 367.500 | - | Aaa | - | - | - | - | - | - | Floating | 3mL | - | - | 3mL+107 | - | - |
| A-1B | USD | 25.500 | - | Aaa | - | - | - | - | - | - | Floating | 3mL | - | - | 3mL+122 | - | - |
| A-2 | USD | 54.750 | - | Aa2 | - | - | - | - | - | - | Floating | 3mL | - | - | 3mL+138 | - | - |
| B | USD | 43.500 | - | A2 | - | - | - | - | - | - | Floating | 3mL | - | - | 3mL+170 | - | - |
| C | USD | 37.500 | - | Baa3 | - | - | - | - | - | - | Floating | 3mL | - | - | 3mL+240 | - | - |
| D-1 | USD | 11.500 | - | Ba3 | - | - | - | - | - | - | Floating | 3mL | - | - | 3mL+500 | - | - |
| D-2 | USD | 11.500 | - | Ba3 | - | - | - | - | - | - | Floating | 3mL | - | - | 3mL+560 | - | - |
| Equity | USD | 58.800 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Explore all other research.